Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab in Advanced Thymic Carcinoma
NCT04321330Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2020
- Primary completion
- Jul 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in thymic carcinoma (TC), sponsored by Roche. Started Aug 2020; status: completed.
02
Drugs
atezolizumab
03
Conditions
thymic carcinoma (TC)
Beyond the preview
Go deeper on NCT04321330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04321330.